Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for VBI Vaccines, Inc. (VBIV : NSDQ)
 
 • Company Description   
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.

Number of Employees: 155

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.04 Daily Weekly Monthly
20 Day Moving Average: 2,085,609 shares
Shares Outstanding: 258.26 (millions)
Market Capitalization: $268.59 (millions)
Beta: 2.01
52 Week High: $4.31
52 Week Low: $0.96
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.77% -21.95%
12 Week -25.71% -19.40%
Year To Date -55.56% -47.15%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
160 Second Street Floor 3
-
Cambridge,MA 02142
USA
ph: 617-830-3031
fax: -
ir@vbivaccines.com http://www.vbivaccines.com
 
 • General Corporate Information   
Officers
Jeffrey Baxter - Chief Executive Officer and President
Christopher McNulty - Chief Financial Officer and Head of Business Devel
Steven Gillis - Director
Michel De Wilde - Director
Blaine McKee - Director

Peer Information
VBI Vaccines, Inc. (CORR.)
VBI Vaccines, Inc. (RSPI)
VBI Vaccines, Inc. (CGXP)
VBI Vaccines, Inc. (BGEN)
VBI Vaccines, Inc. (GTBP)
VBI Vaccines, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 91822J103
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/01/22
Share - Related Items
Shares Outstanding: 258.26
Most Recent Split Date: (:1)
Beta: 2.01
Market Capitalization: $268.59 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.07 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.27 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/01/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.07
Price/Cash Flow: -
Price / Sales: 589.01
EPS Growth
vs. Year Ago Period: -14.29%
vs. Previous Quarter: -14.29%
Sales Growth
vs. Year Ago Period: -58.14%
vs. Previous Quarter: 55.56%
ROE
03/31/22 - -48.77
12/31/21 - -42.79
09/30/21 - -39.02
ROA
03/31/22 - -34.40
12/31/21 - -31.63
09/30/21 - -30.11
Current Ratio
03/31/22 - 3.31
12/31/21 - 4.00
09/30/21 - 4.49
Quick Ratio
03/31/22 - 3.19
12/31/21 - 3.92
09/30/21 - 4.42
Operating Margin
03/31/22 - -16,087.72
12/31/21 - -11,054.36
09/30/21 - -9,290.20
Net Margin
03/31/22 - -16,087.72
12/31/21 - -11,054.36
09/30/21 - -9,290.20
Pre-Tax Margin
03/31/22 - -16,087.72
12/31/21 - -11,054.36
09/30/21 - -9,290.20
Book Value
03/31/22 - 0.50
12/31/21 - 0.56
09/30/21 - 0.63
Inventory Turnover
03/31/22 - 4.09
12/31/21 - 4.80
09/30/21 - 4.65
Debt-to-Equity
03/31/22 - 0.19
12/31/21 - 0.20
09/30/21 - 0.17
Debt-to-Capital
03/31/22 - 16.06
12/31/21 - 16.50
09/30/21 - 14.85
 

Powered by Zacks Investment Research ©